US2007009440A1PendingUtilityA1

Peptide Conjugates and Fluorescence Detection Methods for Intarcellular Caspase Assay

Assignee: APPLERA CORPPriority: May 21, 2001Filed: Jun 29, 2006Published: Jan 11, 2007
Est. expiryMay 21, 2021(expired)· nominal 20-yr term from priority
C07K 5/101C12Q 1/37G01N 2510/00G01N 33/542C07K 7/06C07K 5/1021
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Polypeptides labelled with a donor and acceptor pair of dyes selected from a dibenzorhodamine dye and a diamino-benzophenoxazine dye are peptide conjugates which are useful for intracellular and bead-based assays with fluorescence detection. Peptide conjugates with a caspase-recognition site undergo cleavage into peptide fragments which may be detected, located, and quantitated by the changes in fluorescence. Intracellular cleavage of peptide conjugates is correlated with apoptosis.

Claims

exact text as granted — not AI-modified
1 . A peptide conjugate comprised of: 
 a polypeptide covalently attached to a donor dye through a first linkage and to an acceptor dye through a second linkage,    wherein the donor dye and the acceptor dye is selected from the formula:                          wherein R 13 , R 14 , R 15 , and R 16  are selected from hydrogen, C 1 -C 12  alkyl, C 1 -C 12  alkyldiyl, phenyl, substituted phenyl, benzyl, substituted benzyl, biphenyl, substituted biphenyl, naphthyl, substituted naphthyl, heterocycle, substituted heterocycle, a water-solubilizing group and a linkage;    R 13  when taken together with R 14  is C 2 -C 8  alkyldiyl;    R 15  when taken together with R 16  is C 2 -C 8  alkyldiyl;    R 13  when taken together with R 17  is C 2 -C 8  alkyldiyl;    R 15  when taken together with R 22  is C 2 -C 8  alkyldiyl;    R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , and R 26  are selected from hydrogen, fluorine, chlorine, bromine, C 1 -C 8  alkyl, carboxylate, sulfate, sulfonate, alkylsulfonate, aminomethyl(—CH 2 NH 2 ), aminoalkyl, 4-dialkylaminopyridinium, hydroxymethyl(—CH 2 OH), methoxy(—OCH 3 ), hydroxyalkyl(—ROH), thiomethyl(—CH 2 SH), thioalkyl(—RSH), alkylsulfone(—SO 2 R), arylthio(—SAr), arylsulfone(—SO 2 Ar), sulfonamide(—SO 2 NR 2 ), alkylsulfoxide(—SOR), arylsulfoxide(—SOAr), primary amino(—NH 2 ), ammonium(—NH3 + ), secondary amino(—NHR), tertiary amino(—NR 2 ), quaternary amine(—NR 3   + ), amido(—CONR 2 ), nitrile(—CN), nitro(—NO 2 ), C 1 -C 8  alkoxy(—OR), phenoxy, phenolic, tolyl, phenyl, C 5 -C 20  aryl, benzyl, heterocycle, phosphonate, phosphate, sulfate, polyethyleneoxy, a water-solubilizing group, and a linkage, wherein R is selected from C 1 -C 6  alkyl and C 1 -C 6  alkyldiyl, and Ar is C 5 -C 14  aryl;    R 19  and R 20 , when taken together, are C 5 -C 14  aryleno;    R 24  and R 25 , when taken together, are C 5 -C 14  aryleno;    with the proviso that at least one of R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , and R 26  is the first linkage or the second linkage; and the formula:                          wherein R 1 , R 2 , R 3 , and R 4  are selected from hydrogen, C 1 -C 12  alkyl, C 1 -C 12  alkyldiyl, phenyl, substituted phenyl, benzyl, substituted benzyl, biphenyl, substituted biphenyl, naphthyl, substituted naphthyl, heterocycle, substituted heterocycle, a water-solubilizing group, and a linkage;    R 1  when taken together with R 2  is C 2 -C 8  alkyldiyl;    R 3  when taken together with R 4  is C 2 -C 8  alkyldiyl;    R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12  are selected from hydrogen, fluorine, chlorine, bromine, C 1 -C 8  alkyl, carboxylate, sulfate, sulfonate, alkylsulfonate, aminomethyl(—CH 2 NH 2 ), aminoalkyl, 4-dialkylaminopyridinium, hydroxymethyl(—CH 2 OH), methoxy(—OCH 3 ), hydroxyalkyl(—ROH), thiomethyl(—CH 2 SH), thioalkyl(—RSH), alkylsulfone(—SO 2 R), arylthio(—SAr), arylsulfone(—SO 2 Ar), sulfonamide(—SO 2 NR 2 ), alkylsulfoxide(—SOR), arylsulfoxide(—SOAr), primary amino(—NH 2 ), ammonium(—NH 3   + ), secondary amino(—NHR), tertiary amino(—NR 2 ), quaternary amine(—NR 3   + ), amido(—CONR 2 ), nitrile(—CN), nitro(—NO 2 ), C 1 -C 8  alkoxy(—OR), phenoxy, phenolic, tolyl, phenyl, C 5 -C 20  aryl, benzyl, heterocycle, phosphonate, phosphate, sulfate, polyethyleneoxy, a water-solubilizing group, and a linkage, wherein R is selected from C 1 -C 6  alkyl and C 1 -C 6  alkyldiyl, and Ar is C 5 -C 14  aryl;    R 6  and R 7 , when taken together, is C 5 -C 14  aryleno;    R 10  and R 11 , when taken together, is C 5 -C 14  aryleno;    with the proviso that at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12  is the first linkage or the second linkage.    
     
     
         2 - 54 . (canceled)  
     
     
         55 . An assay method comprising: 
 a) delivering the peptide conjugate of  claim 1  inside a plurality of eukaryotic cells;    b) illuminating the cells; and    c) detecting fluorescence.    
     
     
         56 - 76 . (canceled)  
     
     
         77 . A method of detecting caspase activity comprising: 
 a) suspending the peptide conjugate on a solid support of claim  49  in an aqueous solution containing a caspase in a vessel;    b) illuminating the vessel; and    c) detecting fluorescence in the vessel;    wherein the peptide conjugate has a caspase cleavage site.    
     
     
         78 - 85 . (canceled)  
     
     
         86 . A method of synthesizing a peptide conjugate comprising: 
 a) synthesizing a polypeptide on a solid support;    b) reacting the polypeptide on a solid support with a first dye labelling reagent;    c) cleaving the polypeptide from the solid support; and    d) reacting the cleaved polypeptide with a second dye labelling reagent;    wherein the first dye labelling reagent and the second dye labelling reagent are selected from the formula:                          wherein R 13 , R 14 , R 15 , and R 16  are selected from hydrogen, C 1 -C 12  alkyl, C 1 -C 12  alkyldiyl, phenyl, substituted phenyl, benzyl, substituted benzyl, biphenyl, substituted biphenyl, naphthyl, substituted naphthyl, heterocycle, substituted heterocycle, a water-solubilizing group and a linking moiety;    R 13  when taken together with R 14  is C 2 -C 8  alkyldiyl;    R 15  when taken together with R 16  is C 2 -C 9  alkyldiyl;    R 13  when taken together with R 17  is C 2 -C 8  alkyldiyl;    R 15  when taken together with R 22  is C 2 -C 8  alkyldiyl;    R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , and R 26  are selected from hydrogen, fluorine, chlorine, bromine, C 1 -C 8  alkyl, carboxylate, sulfate, sulfonate, alkylsulfonate, aminomethyl(—CH 2 NH 2 ), aminoalkyl, 4-dialkylaminopyridinium, hydroxymethyl(—CH 2 OH), methoxy(—OCH 3 ), hydroxyalkyl(—ROH), thiomethyl(—CH 2 SH), thioalkyl(—RSH), alkylsulfone(—SO 2 R), arylthio(—SAr), arylsulfone(—SO 2 Ar), sulfonamide(—SO 2 NR 2 ), alkylsulfoxide(—SOR), arylsulfoxide(—SOAr), primary amino(—NH 2 ), ammonium(—NH 3   + ), secondary amino(—NHR), tertiary amino(—NR 2 ), quaternary amine(—NR 3   + ), amido(—CONR 2 ), nitrile(—CN), nitro(—NO 2 ), C 1 -C 8  alkoxy(—OR), phenoxy, phenolic, tolyl, phenyl, C 5 -C 20  aryl, benzyl, heterocycle, phosphonate, phosphate, sulfate, polyethyleneoxy, a water-solubilizing group, and a linking moiety, wherein R is selected from C 1 -C 6  alkyl and C 1 -C 6  alkyldiyl, and Ar is C 5 -C 14  aryl;    R 19  and R 20 , when taken together, are C 5 -C 14  aryleno;    R 24  and R 25 , when taken together, are C 5 -C 14  aryleno;    with the proviso that at least one of R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , and R 26  is linking moiety; and the formula:                          wherein R 1 , R 2 , R 3 , and R 4  are selected from hydrogen, C 1 -C 12  alkyl, C 1 -C 12  alkyldiyl, phenyl, substituted phenyl, benzyl, substituted benzyl, biphenyl, substituted biphenyl, naphthyl, substituted naphthyl, heterocycle, substituted heterocycle, a water-solubilizing group, and a linking moiety;    R 1  when taken together with R 2  is C 2 -C 8  alkyldiyl;    R 3  when taken together with R 4  is C 2 -C 8  alkyldiyl;    R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12  are selected from hydrogen, fluorine, chlorine, bromine, C 1 -C 8  alkyl, carboxylate, sulfate, sulfonate, alkylsulfonate, aminomethyl(—CH 2 NH 2 ), aminoalkyl, 4-dialkylaminopyridinium, hydroxymethyl(—CH 2 OH), methoxy(—OCH 3 ), hydroxyalkyl(—ROH), thiomethyl(—CH 2 SH), thioalkyl(—RSH), alkylsulfone(—SO 2 R), arylthio(—SAr), arylsulfone(—SO 2 Ar), sulfonamide(—SO 2 NR 2 ), alkylsulfoxide(—SOR), arylsulfoxide(—SOAr), primary amino(—NH 2 ), ammonium(—NH 3   + ), secondary amino(—NHR), tertiary amino(—NR 2 ), quaternary amine(—NR 3   + ), amido(—CONR 2 ), nitrile(—CN), nitro(—NO 2 ), C 1 -C 8  alkoxy(—OR), phenoxy, phenolic, tolyl, phenyl, C 5 -C 20  aryl, benzyl, heterocycle, phosphonate, phosphate, sulfate, polyethyleneoxy, a water-solubilizing group, and a linking moiety, wherein R is selected from C 1 -C 6  alkyl and C 1 -C 6  alkyldiyl, and Ar is C 5 -C 14  aryl;    R 6  and R 7 , when taken together, is C 5 -C 14  aryleno;    R 10  and R 11 , when taken together, is C 5 -C 14  aryleno;    with the proviso that at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12  is a linking moiety;    whereby a peptide conjugate is formed.    
     
     
         87 - 88 . (canceled)  
     
     
         89 . A kit comprising the peptide conjugate of  claim 1  and an apoptosis inducer.  
     
     
         90 . A kit comprising the peptide conjugate of  claim 1  and a caspase inhibitor.  
     
     
         91 . A kit comprising the peptide conjugate of  claim 1  and a plurality of eukaryotic cells.  
     
     
         92 . A kit comprising a polypeptide and a first dye labelling reagent and/or a second dye labelling reagent according to  claim 86.

Join the waitlist — get patent alerts

Track US2007009440A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.